Cargando…

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders

Lack of efficacy of many new highly selective and specific drug candidates in treating diseases with poorly understood or complex etiology, as are many of central nervous system (CNS) diseases, encouraged an idea of developing multi-modal (multi-targeted) drugs. In this manuscript, we describe molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivachtchenko, Alexandre V., Lavrovsky, Yan, Okun, Ilya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969713/ https://www.ncbi.nlm.nih.gov/pubmed/27232215 http://dx.doi.org/10.3233/JAD-151146

Ejemplares similares

A Young Lady with AVN after SARS
Publicado: (2008)

Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
por: Shaharir, Syahrul Sazliyana, et al.
Publicado: (2021)

Aprotinin—Drug against Respiratory Diseases
por: Ivachtchenko, Alexandre V., et al.
Publicado: (2023)

Radiological manifestation of avascular necrosis (AVN) in sickle cell disease (SCD): a review of diagnostic imaging
por: Mohamed Aziz Bedair, Elsaid, et al.
Publicado: (2023)

Hip Arthroscopy as Part of a Salvage Procedure for Avascular Necrosis (AVN) in a 7-Year-Old Child
por: Delniotis, Ioannis, et al.
Publicado: (2019)

P25 AVN and complication rate following Intracapsular fracture Neck of Femur fixation in the under 60s. – Derby experience
por: Sian, Ross, et al.
Publicado: (2021)

L-type calcium channels as drug targets in CNS disorders
por: Ortner, Nadine J, et al.
Publicado: (2015)

Nanotechnology-based drug delivery for the treatment of CNS disorders
por: Mittal, Khushi R., et al.
Publicado: (2022)

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders
por: Estrada, José Antonio, et al.
Publicado: (2020)

Case report: AVN of the femoral head five year follow-up of the combination of ipsilateral femoral neck and sub-trochanteric fracture
por: Zhang, Wei, et al.
Publicado: (2016)

Conduction delays across the specialized conduction system of the heart: Revisiting atrioventricular node (AVN) and Purkinje-ventricular junction (PVJ) delays
por: Choi, Bum-Rak, et al.
Publicado: (2023)

Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets
por: Kharkar, Prashant S.
Publicado: (2014)

Inhibitory Effect of Avenanthramides (Avn) on Tyrosinase Activity and Melanogenesis in α-MSH-Activated SK-MEL-2 Cells: In Vitro and In Silico Analysis
por: Park, Jun-Young, et al.
Publicado: (2021)

Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery
por: Meyer, Axel H., et al.
Publicado: (2023)

Fibrin-targeting molecular MRI in inflammatory CNS disorders
por: Lohmeier, Johannes, et al.
Publicado: (2022)

Extracardiac Vagal Stimulation-Assisted Cardioneuroablation: Dynamically Evaluating the Impact of Sequential Ganglionated Plexus Ablation on Vagal Control of SAN and AVN in Patients with Sinoatrial Node Dysfunction
por: Chen, Weijie, et al.
Publicado: (2022)

Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s Disease
por: Fancellu, Gaia, et al.
Publicado: (2019)

Botanical Formula LCS101: A Multi-Targeted Approach to Cancer Care
por: Maimon, Yair, et al.
Publicado: (2018)

The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2
por: Ivashchenko, Andrey A., et al.
Publicado: (2022)

Prospects for repurposing CNS drugs for cancer treatment
por: Abdelaleem, Mohamed, et al.
Publicado: (2019)

Identification and modeling of a drug target for Clostridium perfringens SM101
por: Chhabra, Gagan, et al.
Publicado: (2010)

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders
por: Lui, Austin, et al.
Publicado: (2022)

[(99m) Tc] Tc‐MDP bone SPECT/CT diagnosing unstable slipped capital femoral epiphysis with secondary AVN in a patient with misleading knee pain
por: Ebrahimi, Marzieh, et al.
Publicado: (2023)

Editorial: New GPCR targets and modulators to treat CNS disorders
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Antibody-based Validation of CNS Ion Channel Drug Targets
por: Rhodes, Kenneth J., et al.
Publicado: (2008)

Degeneration of three or more lumbar discs significantly decreases lumbar spine/hip ROM ratio during position change from standing to sitting in AVN patients before THA
por: Gu, Jianming, et al.
Publicado: (2020)

Transcutaneous Auricular Vagus Nerve Stimulation (tAVNS) Delivered During Upper Limb Interactive Robotic Training Demonstrates Novel Antagonist Control for Reaching Movements Following Stroke
por: Chang, Johanna L., et al.
Publicado: (2021)

Challenges in the diagnosis and treatment of CNS demyelinating disorders in Zambia
por: Miskin, Dhanashri P, et al.
Publicado: (2016)

Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
por: Guo, Zi-Hua, et al.
Publicado: (2023)

General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNS
por: Ayzenberg, Ilya, et al.
Publicado: (2019)

The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders
por: Jóźwiak-Bębenista, Marta, et al.
Publicado: (2022)

Nanogels as novel drug nanocarriers for CNS drug delivery
por: Manimaran, V., et al.
Publicado: (2023)

Genome Editing for CNS Disorders
por: Duarte, Fábio, et al.
Publicado: (2020)

Perispinal Delivery of CNS Drugs
por: Tobinick, Edward Lewis
Publicado: (2016)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2018)

Potential Molecular Targets in the Treatment of Patients with CNS Tumors
por: Pan, Edward
Publicado: (2023)

Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs
por: Dwyer, Donard S., et al.
Publicado: (2014)

Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets
por: Jin, Bo, et al.
Publicado: (2023)

The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes
por: Halperin-Sheinfeld, Meital, et al.
Publicado: (2012)

Connexin Hemichannels in Astrocytes: Role in CNS Disorders
por: Xing, LingYan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8kumpgq6cafstvon1res003d9e